APA

Kim D. Y., Park E. Y., Chang E., Kang H., Koo Y., Lee E. J., Ko J. Y., Kong H. K., Chun K. & Park J. H. (20180123). A novel miR-34a target, protein kinase D1, stimulates cancer stemness and drug resistance through GSK3/β-catenin signaling in breast cancer. : Oncotarget.

Chicago

Kim Do Yeon, Park Eun Young, Chang EunSun, Kang Hyeok-Gu, Koo Yoonjin, Lee Eun Ji, Ko Je Yeong, Kong Hyun Kyung, Chun Kyung-Hee and Park Jong Hoon. 20180123. A novel miR-34a target, protein kinase D1, stimulates cancer stemness and drug resistance through GSK3/β-catenin signaling in breast cancer. : Oncotarget.

Harvard

Kim D. Y., Park E. Y., Chang E., Kang H., Koo Y., Lee E. J., Ko J. Y., Kong H. K., Chun K. and Park J. H. (20180123). A novel miR-34a target, protein kinase D1, stimulates cancer stemness and drug resistance through GSK3/β-catenin signaling in breast cancer. : Oncotarget.

MLA

Kim Do Yeon, Park Eun Young, Chang EunSun, Kang Hyeok-Gu, Koo Yoonjin, Lee Eun Ji, Ko Je Yeong, Kong Hyun Kyung, Chun Kyung-Hee and Park Jong Hoon. A novel miR-34a target, protein kinase D1, stimulates cancer stemness and drug resistance through GSK3/β-catenin signaling in breast cancer. : Oncotarget. 20180123.